MannKind | Profitto Lordo Sulle Vendite

	Gross Profit On Sales	Cambiamento		Data
Adma Biologics	USD 63.33M		3.67M	2024-12
Dynavax Technologies	USD 58.62M		8.92M	2024-12
Eli Lilly	USD 11.13B		1.86B	2024-12
Halozyme Therapeutics	USD 255.95M		15.3M	2024-12
Insmed	USD 78.29M		6.04M	2024-12
MacroGenics	USD 108.84M		100.86M	2024-09
MannKind	USD 59.17M		6.82M	2024-12
Merck	USD 11.92B		852M	2024-12
Novo Nordisk	DKK 60B		2.22B	2024-09
Pfizer	USD 12.11B		718M	2024-12
Sanofi	EUR 10.07B		2.1B	2024-09
Xencor	-45143000		40.69M	2024-09

MannKind Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.